Please ensure Javascript is enabled for purposes of website accessibility

It Pays to Invest Like a Dog

By Tamara Walsh – Updated Apr 6, 2017 at 4:52PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out how the Dow's best dividend stocks can work for you.

The Dogs of the Dow strategy is a low-maintenance approach for investors who value a company based on the dividend it pays. It's a stock-picking method in which your returns are fixed to the 10 highest-yielding stocks in the Dow Jones Industrial Average. Let's see how 2011's Dogs (picked at the end of 2010) have performed thus far, and which stocks look most promising.

Top dogs
This year's Dogs of the Dow are listed in descending order by 2010 year-end yields.

Companies

2010 Year-End Yields

Current Yield

AT&T 5.85% 5.87%
Verizon 5.46% 5.41%
Pfizer (NYSE: PFE) 4.57% 4.15%
Merck (NYSE: MRK) 4.22% 4.41%
Kraft Foods 3.68% 3.30%
Johnson & Johnson (NYSE: JNJ) 3.49% 3.54%
Intel (Nasdaq: INTC) 3.42% 3.42%
DuPont (NYSE: DD) 3.29% 3.41%
McDonald's (NYSE: MCD) 3.18% 3.03%
Chevron (NYSE: CVX) 3.16% 3.16%

Source: Yahoo! Finance.

This year, investors have endured increasing levels of uncertainty in the stock market. The year-to-date return of the Dow Jones Industrials is about 3.5%, or roughly 5.5% if you add in the dividends. Through the first three quarters of 2011, the straight return for the Dogs is more than 7% -- factor in dividend reinvestments and the return climbs to 11%.

These returns put the Dogs of the Dow on track to beat the broader index this year. That sounds great, until you consider the strategy's historical data. The Dogs of the Dow have underperformed the Dow Jones Industrial Index in 10 of the past 15 years.

Given the mixed performance of this strategy in the past, I recommend using the Dogs of the Dow as more of a starting point for your research, versus a rapid-fire approach to stock picking. A deeper look at our top dogs will give us a clearer picture of which stocks are leading the pack.

In dog we trust
DuPont and Merck get factored out right off the bat for being the only two stocks of the top 10 that posted share-price declines for the period. On the flip side, stocks bringing in the highest returns included McDonald's at almost 25%, Chevron at 19%, and Intel at 17%.

Of this year's biggest winners, pharmaceutical company Pfizer features the highest dividend yield. However, the company will lose its patent protection for Pfizer's cholesterol-fighting drug, Lipitor, later this year -- costing the drug maker future sales.

Chevron Corporation Dividend Yield Chart

Chevron Corporation Dividend Yield Chart by YCharts

With Pfizer on watch for the impending patent loss, Chevron emerges as our clear winner. The energy stock has a solid dividend yield, and dividend investors will also like Chevron's strong history of paying out dividends, in fact, the company has increased its dividend for the past 24 years straight.

Bone up
The Dogs of the Dow is a simple strategy that makes for a good starting point for investors. A closer look at the top 10 stocks will help investors look beyond a stock's yield to the company behind that stock. Learn when these stocks are trading at an attractive valuation by adding them to The Motley Fool's free tracking tool: My Watchlist.

Fool contributor Tamara Rutter owns no shares of any of the companies mentioned. Follow her on Twitter, where she goes by @TamaraRutter. The Motley Fool owns shares of Intel and Johnson & Johnson and has bought calls on Intel. Motley Fool newsletter services have recommended buying shares of Intel, Johnson & Johnson, McDonald's, Pfizer, and Chevron, as well as creating a bull call spread position in Intel and a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$44.08 (-1.10%) $0.49
Chevron Corporation Stock Quote
Chevron Corporation
CVX
$144.77 (-6.53%) $-10.12
McDonald's Corporation Stock Quote
McDonald's Corporation
MCD
$245.95 (-0.80%) $-1.99
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
Intel Corporation Stock Quote
Intel Corporation
INTC
$27.52 (-1.96%) $0.55
Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
MRK
$86.78 (-0.83%) $0.73
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$166.72 (0.33%) $0.54

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.